PetMed Express, Inc. (PETS) is a publicly traded Healthcare sector company. As of November 17, 2026, PETS trades at $0.89 with a market cap of $19.96M and a P/E ratio of -0.95. PETS moved -0.86% today. Year to date, PETS is -72.77%; over the trailing twelve months it is -54.29%. Its 52-week range spans $0.85 to $4.32. Analyst consensus is sell with an average price target of $1.40. Rallies surfaces PETS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Petmed Express Q2 revenue falls 19% to $35.8 million: Petmed Express reported second-quarter revenue of $35.8 million, down 19% year over year, mainly due to lower prescription sales and more promotions. Net loss narrowed to $6.4 million, while adjusted EBITDA loss widened to $3.6 million.
| Metric | Value |
|---|---|
| Price | $0.89 |
| Market Cap | $19.96M |
| P/E Ratio | -0.95 |
| EPS | $-1.38 |
| Dividend Yield | 0.30% |
| 52-Week High | $4.32 |
| 52-Week Low | $0.85 |
| Volume | 52.72K |
| Avg Volume | 0 |
| Revenue (TTM) | $168.86M |
| Net Income | $-29.28M |
| Gross Margin | 27.92% |
1 analysts cover PETS: 0 strong buy, 0 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is sell. Average price target: $1.40.